BIOCRYST PHARMACEUTICALS, INC. (BCRX) Free cash flow 2017–2019
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$89.9MFY2019 · since FY2017: -$41.5M → -$89.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$89.9M | +3.2% |
| FY2018 | -$92.9M | -124.1% |
| FY2017 | -$41.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice